If you are an investor and would be interested in trial access, the Basic content is available on a two-week trial once the trial subscription agreement is in place.
Managers may achieve a tight BB print where the new issue portfolio carries a tight WAS and is viewed as clean. More broadly, new issue BB tranche pricing can serve as a useful barometer of a manager’s debt performance, particularly when assessed against MVOC metrics.
As of 9 February 2026, the arbitrage metric for non-short-dated US CLOs has improved, reflecting a widening four-week moving-average loan discounted spread alongside tight liability prints. At approximately 173 bps, this has returned to levels last seen in early July 2025.
The analysis covers 1,719 US BSL CLO deals across vintages from 2012 to 1H 2025, excluding deals with a collateral pool factor below 55%. Based on asset prices as at 5 February 2026, the overall median below-80 exposure stood at 4.7%, which is elevated from a CLO equity perspective. Such exposures are typically penalised in cashflow modelling, weighing on CLO equity valuations.
Below are tables presenting the MVOC (AAA-B) and EQ NAV of US BSL CLO deals by vintage, based on asset prices as of February 5, 2026.
US CLOs’ aggregate exposure to the Skopima Consilio Parent LLC term loan is approximately USD 1.365 billion, placing it among the top 200 holdings across all US CLOs. As of 5 February 2026, 799 US CLO deals, managed by 55 managers, reported an average deal-level exposure of around 47 bps.
US CLOs’ overall exposure to Smartbear Software term loan is approximately USD 428.3 million. As of 5 February 2026, 249 US CLO deals, managed by 14 managers, reported an average deal-level exposure of around 36 bps.
OHA Credit Funding 17-R (Oak Hill Advisors, L.P.) sets new records in the US BSL CLO 2.0 market: BB at 425 bps (tightest on record), AAA at 114.7 bps, and an AAA–BB pricing differential of 310.3 bps — also a record low.
Monday's BWIC activity highlighted a wide dispersion in pricing across seasoned US CLO BB tranches with 2026–2027 reinvestment end dates,...
Against the backdrop of a much tighter WACC, EU primary CLOs are now generating arbitrage of around 180 bps, which represents a healthy level for the market compared with the past six to seven months.
US CLOs’ overall exposure to Kofax term loan is approximately USD 567 million. As of 3 February 2026, 294 US CLO deals, managed by 21 managers, reported an average deal-level exposure of around 48 bps.
Based on EU CLO AAA BWIC colour observed since 9 January 2026, the table below summarises the best DM prints across each WAL. For context, Bridgepoint CLO X is currently being marketed with the AAA tranche talked at around 121 for a WAL of approximately six years.
RRE 19’s 122 bps print appears to offer attractive value, while the AAA prints for Bilbao CLO II and Henley CLO VII are broadly in line with median reset market levels.
AAA tranches continue to lag the broader spread-compression trend. While top-tier BB tranches have tightened to around 430 DM, AAA levels, at 117 bps, remain wider than the 113 bps seen in February 2025. This has pushed the AAA–BB pricing differential to a new record tight of roughly 317 bps in the CLO 2.0 market.
Below are tables presenting the MVOC (AAA-B) and EQ NAV of US BSL CLO deals by vintage, based on asset prices as of January 30, 2026.
Tracking exposure to underlying CLO collateral priced below 80 and 70 can serve as a useful proxy for assessing tail risk within the asset pool. While this metric has inherent limitations—most notably that it does not capture stressed or distressed positions that have already been traded out of the collateral pools—it nevertheless provides a timely and standardised snapshot of downside risk embedded within CLO collateral portfolios.
